Viktoria Hjalmar

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Jeanette Lundin, Eva Kimby, Magnus Björkholm et al. · Blood · 2002 · 499 citations · Full text

Medicine, Hematology, Oncology +16

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study

Tarec Christoffer El‐Galaly, Lasse Hjort Jakobsen, Martin Hutchings et al. · Journal of Clinical Oncology · 2015 · 93 citations · Full text

Medicine, Hematology, Oncology +15

Cell surface expression of CD25, CD54, and CD95 on B‐ and T‐cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course

Viktoria Hjalmar, Robert Hast, Eva Kimby · European Journal Of Haematology · 2002 · 33 citations

Medicine, Hematology, Immunology +14

Successful Treatment with Fludarabine in Two Cases of Angioimmunoblastic Lymphadenopathy with Dysproteinemia

Robert Hast, Björn Jacobsson, A Petrescu et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1999 · 31 citations

Medicine, Hematology, Oncology +16

Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-cell disorders.

Viktoria Hjalmar, Eva Kimby, E Matutes et al. · PubMed · 1998 · 31 citations

Life Sciences, Genetics, Hematology +17